Role of Irbesartan on cardiac endothelial-to-mesenchymal transition in diabetic rats
10.3760/cma.j.issn.1001-7097.2015.05.006
- VernacularTitle:厄贝沙坦对糖尿病大鼠心肌内皮细胞转分化的作用
- Author:
Rining TANG
;
Dongdong ZHU
;
Yuchen HAN
;
Min WU
;
Linli LYU
;
Kunling MA
;
Bicheng LIU
- Publication Type:Journal Article
- Keywords:
Fibrosis;
Diabetes;
Cell transdifferentiation;
Irbesartan
- From:
Chinese Journal of Nephrology
2015;31(5):351-358
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the effect of irbesartan on cardiac endothelial-mesenchymal transition (EndMT) in diabetic rats.Methods The model of diabetic rat was induced by intraperitoneal injection with streptozotocin (STZ,35 mg/kg) in spontaneous hypertensive rats (SHR).Diabetic rats were divided into diabetic group and the Irbesartan treated group.The pathological changes were investigated by fluorescence microscope and electron microscope.The EndMT was studied in human aortic endothelial cells (HAEC) exposure to high glucose.The concentration of angiotensin Ⅱ in the supernatant was detected by radioimmunoassay.Immunofluorescence staining was performed to detect the co-localization of CD31 and FSP1.Results The significant myocardial fibrosis was presented in the diabetic group.Endothelial protrusions were prominent feature in myocardial microvascular of diabetic rat compared with the control group rats.Double staining of HAEC showed co-localization of CD31 and FSP1,which was decreased by the treatment of Irbesartan (P ＜ 0.05).When HAEC was exposed to high glucose,it showed some cells acquired spindle-shaped morphology and lost CD31 staining,and FSP1 and α-SMA protein expression levels were markedly upregulated,which attenuated by the treatment of Irbesartan.Conclusion Irbesartan might prevent diabetes from myocardial fibrosis via inhibition of EndMT in diabetic rats.
